Kan. Admin. Regs. § 28-4-501 - Definitions
(a) "Applicable
income" means the total monies received by all adult members of the family
based on any of the following, with the addition of nontaxable benefits from
any private, state, and federal funding sources:
(1) The total amount of adjusted gross income
reported on one of the federal income tax forms 1040, 1040A, or 1040EZ,
including a copy of all W-2 forms filed by each adult member of the family;
(2) the six most recent pay stubs;
or
(3) a letter of anticipated
earnings from the employer of each adult member of the family if the most
recent federal income tax form does not reflect current income.
(b) "Birth attendant" means the
person assisting with an out-of-institution delivery of the infant, in the
absence of a physician.
(c)
"Borderline hypothyroid" means an abnormally low level of thyroxine and a
higher than normal level of thyroid-stimulating hormone in the blood, the
combination of which is not usually indicative of hypothyroidism.
(d) "Cash assets" means accessible money,
including savings accounts, certificates of deposit, checking accounts, stocks,
and bonds. This term shall not include individual retirement accounts and
retirement plans.
(e) "Department"
means the Kansas department of health and environment.
(f) "Eligible person" means an individual who
qualifies for any necessary treatment products or medically necessary food
treatment products, or both.
(g)
"Family," for the purposes of these regulations, means an eligible person who
meets one of the following conditions and all other persons who reside in the
home with the eligible person;
(1) Resides
with and is considered to be a dependent of the person's parents, stepparents,
or legal guardian for income tax purposes; or
(2) establishes a separate residence and is
no longer considered a dependent of the person's parents, stepparents, or legal
guardian for income tax purposes.
The term "family" shall not include any person who leases or rents a portion of the residence or who lives with the other persons who are not responsible for the financial support of the eligible person.
(h)
"Galactosemia" means the disease of genetic origin due to galactose uridyl
transferase enzyme deficiency in which the individual is completely or
partially incapable of normal metabolism of galactose, which results in an
abnormal increase in the concentration of galactose in the blood.
(i) "Hemoglobin disease" means the presence
of abnormal hemoglobin and the absence of adult hemoglobin, the combination of
which is indicative of disease and requires ongoing medical treatment.
(j) "Hemoglobin trait" means the
presence of abnormal hemoglobin, which is not indicative of disease and does
not usually require ongoing medical treatment.
(k) "Hypothyroidism" means a congenital
disease in which the individual is unable to produce thyroxine normally, which
may be detected by an abnormally low serum level of thyroxine and an abnormally
high serum level of thyroid-stimulating hormone in the blood. For purposes of
these newborn screening regulations, this term shall exclude diseases referred
to as secondary hypothyroidism.
(l) "Institution" means a hospital or other
organized agency providing obstetrical services.
(m) "Kit" means the multiple-page laboratory
requisition with the attached filter paper to be used for blood collection and
with a place for identifying the infant, physician, and sending agency data.
The kits shall be provided by the department.
(n) "Laboratory" means the division of health
and environmental laboratories, Kansas department of health and environment.
(o) "Maple syrup urine disease"
and "MSUD" mean an inherited disease of amino acid metabolism that causes
acidosis, central nervous system symptoms, and urine that can smell sweet like
maple syrup.
(p) "Medical
specialist" means a medical doctor who has training in the treatment of a
specific disease entity and who has a contract with the department to serve as
a consultant and to provide or direct diagnosis and treatment services.
(q) "Medically necessary food
treatment product" means a specifically formulated product that has less than
one gram of protein per serving and is intended to be used under the direction
of a physician for the dietary treatment of any inherited metabolic disease.
This term shall not include any foods that are naturally low in protein.
(r) "Necessary treatment product"
means a medical protein source used under the direction of a physician to treat
specific metabolic diseases in order to prevent, delay, or reduce medical
complications.
(s) "Newborn
screening coordinator" means the designee in the department providing the
follow-up program activities.
(t)
"Other genetic disease" means any condition inherited in a recognized pattern
that can be detected in a filter paper blood specimen and that the secretary
has designated as part of the newborn screening battery of tests.
(u) "Phenylketonuria" and "PKU" mean any
disease, usually due to a single enzyme deficiency of genetic origin, in which
the individual is completely or partially incapable of normal metabolism of
phenylalanine, which results in an abnormal increase in the concentration of
phenylalanine in the blood.
(v)
"Presumptive positive" means a screening test result that indicates the
possible presence of a disease, requiring further testing to confirm or not
confirm the diagnosis.
(w)
"Secretary" means the secretary of the Kansas department of health and
environment.
(x) "Sending agency"
means the agency or person identified on the kit to be the recipient of the
report.
(y) "Specimen" means the
saturated blood spots on the filter paper and the laboratory requisition with
complete identifying data on the infant, physician, and sending agency.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.